Eriksson David, Stigbrand Torgny
Department of Immunology, University of Umeå, 90185 Umeå, Sweden.
Tumour Biol. 2010 Aug;31(4):363-72. doi: 10.1007/s13277-010-0042-8. Epub 2010 May 20.
The main goal when treating malignancies with radiation therapy is to deprive tumor cells of their reproductive potential. One approach to achieve this is by inducing tumor cell apoptosis. Accumulating evidences suggest that induction of apoptosis alone is insufficient to account for the therapeutic effect of radiotherapy. It has become obvious in the last few years that inhibition of the proliferative capacity of malignant cells following irradiation, especially with solid tumors, can occur via alternative cell death modalities or permanent cell cycle arrests, i.e., senescence. In this review, apoptosis and mitotic catastrophe, the two major cell deaths induced by radiation, are described and dissected in terms of activating mechanisms. Furthermore, treatment-induced senescence and its relevance for the outcome of radiotherapy of cancer will be discussed. The importance of p53 for the induction and execution of these different types of cell deaths is highlighted. The efficiency of radiotherapy and radioimmunotherapy has much to gain by understanding the cell death mechanisms that are induced in tumor cells following irradiation. Strategies to use specific inhibitors that will manipulate key molecules in these pathways in combination with radiation might potentiate therapy and enhance tumor cell kill.
用放射疗法治疗恶性肿瘤时的主要目标是剥夺肿瘤细胞的增殖潜能。实现这一目标的一种方法是诱导肿瘤细胞凋亡。越来越多的证据表明,仅诱导凋亡不足以解释放射疗法的治疗效果。在过去几年中已经很明显,照射后抑制恶性细胞的增殖能力,尤其是实体瘤,可通过替代性细胞死亡方式或永久性细胞周期停滞(即衰老)发生。在这篇综述中,将根据激活机制对放射诱导的两种主要细胞死亡——凋亡和有丝分裂灾难进行描述和剖析。此外,还将讨论治疗诱导的衰老及其与癌症放射治疗结果的相关性。强调了p53在这些不同类型细胞死亡的诱导和执行中的重要性。通过了解照射后肿瘤细胞中诱导的细胞死亡机制,放射疗法和放射免疫疗法的效率有望大幅提高。使用特异性抑制剂来操纵这些途径中的关键分子并结合放射治疗的策略可能会增强治疗效果并提高肿瘤细胞杀伤力。